To the best of our knowledge, this report is the first to describe the quantitative assessment of BMI1 mRNA levels in whole blood from NSCLC patients and evaluating the impact of the expression level on treatment response and prognosis. The gene discussed is BMI1; the disease is non-small cell lung carcinoma.